What is LINC? A multicenter, randomized, controlled trial

Slides:



Advertisements
Similar presentations
Third Annual EMS R ESEARCH S UMMIT Third Annual EMS R ESEARCH S UMMIT.
Advertisements

Results of the Prospective, Randomized, Multicenter FDA Investigational Device Exemption Study of the ProDisc-L Total Disc Replacement Versus Circumferential.
Presenters for Journal Club: James Cooper Eugenie Shieh Aaron Schueneman Tim Niessen.
Final version 1, RESUSCITATION OUTCOMES CONSORTIUM C ontinuous C hest C ompressions Trial Final version 1,
In-hospital Cardiac Arrest: First and foremost, Chest Compressions Charles L Campbell MS MD Associate Professor of Medicine University of Kentucky College.
Targeted Temperature Management TTM-trial investigators
ZOLL AutoPulse ® Non-invasive Cardiac Support Pump.
Recombinant Factor VIIa as Adjunctive Therapy for Bleeding Control in Severely Injured Trauma Patients: Two Parallel Randomized, Placebo-Controlled, Double-
Dallas 2015 TFQO: David Stanton COI 328 EVREVs: Volker Wenzel COI 253& Emmanuelle Bourdon COI 333 Taskforce: BLS Passive ventilation techniques.
Update on Cardiopulmonary Resuscitation
Out-of-Hospital Cardiac Arrest Survival after the Sequential Implementation of 2005 AHA Guidelines for Compressions, Ventilations, and Induced Hypothermia.
Post-Event Hypothermia Julie Swain M.D. Cardiovascular Surgeon Consultant to the FDA Circ System Devices Advisory Panel Sept 2004 DRAFT slides.
INCLUSION/EXCLUSION CRITERIA 1. The following are considerations when defining the cardiac arrest trial patient population (i.e., the inclusion/exclusion.
Dallas 2015 TFQO: EVREVs: Aaron Donoghue / Jonathan Duff Taskforce: EIT Teaching Compression-Only CPR.
6th June 2004 By Norah A A Al Khathlan M.D. JOURNAL CLUB A Comparison of High-Dose and Standard-dose Epinephrine in Children with Cardiac Arrest NEJM 350;17April.
COURAGE: Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation Purpose To compare the efficacy of optimal medical therapy (OMT)
Significant factors in predicting sustained ROSC (return of spontaneous circulation) in paediatric patients with traumatic out- of-hospital cardiac arrest.
Why Emergency Physicians Don’t Care about Cardiac Arrest and Should. Robert Swor, DO Professor, Emergency Medicine Oakland University William Beaumont.
Monthly Journal article review: Vimmi Kang PGY 2
ITU Teaching Friday 5 th April 2013 Association of Prehospital Advanced Airway Management With Neurologic Outcome and Survival in Patients With Out-of-Hospital.
Analysis Section Research Design. Protocol Overview Background4-5 pages Question/Objective/Hypothesis4 lines Design4-20 lines Study Population0.5-1 page.
CAT Review Therapeutic hypothermia for neuroprotection in adults after cardiopulmonary resuscitation Rosie Macfadyen SpR Intensive Care Unit, Royal Infirmary.
Top Papers in Critical Care 2013 Janna Landsperger RN, MSN, ACNP-BC.
Dallas 2015 TFQO: Michael Sayre COI #400 EVREV 1: Mohamud Daya COI #327 EVREV 2: Jan-Thorsten Gräsner COI #230 Taskforce: BLS BLS 363: CPR Prior to Defibrillation.
Chicago 2014 TFQO: Charles Deakin #329 EVREV 1: Asger Granfeldt COI #63 EVREV 2: Bo Lofgren COI #363 Taskforce: ALS ALS 571 : Ventilation strategy post-ROSC.
Dallas 2015 TFQO: Allan de Caen COI #38 EVREV 1: Tia Raymond COI #153; EVREV 2: Jonathan Egan COI #44 Taskforce: Peds The role of invasive vascular monitoring.
Dallas 2015 TFQO: Vinay Nadkarni #375 EVREV 1: Vinay Nadkarni #375 EVREV 1: Dave Kloeck #126 Taskforce: Paeds Paed 424: Vasopressors in Paediatric cardiac.
Dallas 2015 TFQO: Monica Kleinman COI #353 EVREV 1: Janice Tijssen COI#232 EVREV 2: Javier Urbano COI#240 Taskforce: Peds Peds 815: Pediatric goal-directed.
Dallas 2015 TFQO: Judith Finn EVREVs: Judith Finn #227 / Dion Stub #COI Taskforce: EIT Cardiac Arrest Centres.
Dallas 2015 TFQO: Michael W. Donnino COI# EVREVs: Katherine M. Berg COI# Lars W. Andersen COI# Taskforce: ALS Ultrasound During CPR.
EVEREST II Study Design Multicenter Randomized in a 2:1 ratio to either percutaneous or conventional surgery for the repair or replacement of the mitral.
Dallas 2015 TFQO: Koen Monsieurs 372 EVREV 1: Koen Monsieurs 372 EVREV 2: Ahamed Idris 349 Taskforce: BLS BLS366 Chest Compression Depth (adults)
Dallas 2015 TFQO: Jerry Nolan #310 EVREV 1: Jerry Nolan COI #301 EVREV 2: Jan-Thorsten Graesner COI #150 Taskforce: ALS ALS 783 : Advanced versus basic.
Dallas 2015 TFQO: Robert Greif EVREVs: Dana Edelson, COI #334 Robert Greif, COI #344 Taskforce: EIT EIT 645: Debriefing of resuscitation performance.
LINC Trial LUCAS in cardiac arrest trial. What is LINC? A multicenter, randomized, controlled trial designed to evaluate the efficacy and safety of: LUCAS.
Introduction Therapeutic hypothermia has been shown to improve survival and neurologic outcome in patients resuscitated after ventricular fibrillation.
Do IV Meds Matter in Out-of-Hospital Cardiac Arrest? Summary and Comment by John A. Marx, MD, FAAEM Published in Journal Watch Emergency Medicine December.
A Resuscitation Protocol That Minimizes Hands- Off Time Improves Survival Summary and Comment by Aaron E. Bair, MD, MSc, FAAEM, FACEP Published in Journal.
Resuscitation Update 2015 AHA Guidelines 2015 An overview of what’s new… Ed Racht Lynn White.
Dallas 2015 TFQO: Jonathan Witt (COI #418) EVREVs: Steve Lin (COI #137), Thomas Pellis (COI #186) and Katie Dainty (COI #) Taskforce: ALS ALS 428 : Antiarrhythmic.
Continuing Education Summary ICEMA CPR Update 2010.
Abstract Cardiopulmonary Resuscitation with Rescue Breathing Is Superior to Hands-Only Cardiopulmonary Resuscitation for Children and Infants: Results.
Work disability after out-of- hospital-cardiac-arrest in Maribor, Slovenia Katja Lah, MD PhD Assistant professor Zalika Klemenc-Ketiš, MD PhD.
Dallas 2015 TFQO: Jasmeet Soar #COI 409 EVREV 1: Jasmeet Soar #COI 409 EVREV 2: Anthony Lagina #COI 357 Taskforce: ALS ALS 889 OXYGEN DOSE DURING CPR IN.
Uncontrolled organ donation after circulatory death protocols in out-of-hospital cardiac arrests. A potential solution to organ shortage? Alexandre Garioud1*,
A European, multicenter, randomized controlled trial
Targeted temperature management at 33⁰c vs 36⁰c after cardiac arrest
Quality Improvement for Prehospital Cardiac Arrest Management
Mechanical Compressions versus Manual Compressions in Cardiac Arrest
The efficacy and safety of oral Rivaroxaban in patients with permanent inferior vena cava filter: a pilot case-control study Lobastov K., Barinov V.,
SOCRATES Trial design: Patients with acute ischemic stroke were randomized in a 1:1 fashion to receive either ticagrelor 180 mg load + 90 mg BID or aspirin.
Extracorporeal Cardiopulmonary Resuscitation (ECPR) in Adults:
ALS2 Recertification Course
Volume 385, Issue 9972, Pages (March 2015)
PROPPR Transfusion of Plasma, Platelets, and Red Blood Cells in a 1:1:1 vs a 1:1:2 Ratio and Mortality in Patients With Severe Trauma. 
Learning Objectives Current Practices in Ruling Out AMI.
MASTER Trial Inclusion Criteria
ALPS Trial design: Patients with adult nontraumatic out-of-hospital cardiac arrest (OOHCA) and persistent or recurrent VT/VF after ≥1 shock were randomized.
ATMOSPHERE Trial design: Patients with symptomatic heart failure were randomized in a 1:1:1 fashion to either aliskiren 300 mg once daily, enalapril 5.
Monthly Journal article review: Vimmi Kang PGY 2
Per Nordberg, MD, PhD, Principal Investigator
Impedence-guided management
Outcomes After Ventricular Fibrillation Out-of-Hospital Cardiac Arrest: Expanding the Chain of Survival  T. Jared Bunch, MD, Stephen C. Hammill, MD, Roger.
Ischemic Postconditioning
DANAMI 3-DEFER Trial design: Patients presenting with STEMI and in whom the operators could establish TIMI 2-3 flow without stenting or those presenting.
Primary safety endpoint
HeartSafe Community A Proposal to Make Your City the Best Place in the World to be if you have a Sudden Cardiac Arrest.
Continuous chest compression versus interrupted chest compression for cardiopulmonary resuscitation… of nonasphyxial out-of-hospital cardiac arrest Dr.
Νέες μελέτες & νέες τεχνολογίες στην αναζωογόνηση
Figure 1. Flowchart for selection of study participants.
Presentation transcript:

What is LINC? A multicenter, randomized, controlled trial designed to evaluate the efficacy and safety of: LUCAS concept for resuscitation of OHCA including defibrillation during ongoing compressions vs. manual CPR according to 2005 guidelines

Objectives Primary Superiority in 4-hr survival Secondary Survival upto 6 month with good neurological outcome CPC 1-2

Inclusion/Exclusion criteria Inclusion criteria Unexpected adult out-of-hospital cardiac arrest where an attempt of resuscitation is considered appropriate Exclusion critera Traumatic cardiac arrest, including hanging Age believed to be < 18 years Known pregnancy Patients body size not fitting the LUCAS Defibrillated -before LUCAS arrives at scene -crew witnessed VF/VT with ROSC some of the most viable patients have been excluded

Outcome 4-hour survival: Risk difference -0.05% 95% C.I. -3.32 – 3.23, p=1.00 4-hour survival 23.6% 23.7%

Conclusions Mechanical chest compressions using the LUCAS device in combination with defibrillation during ongoing compressions provided no improved 4-hour survival compared to conventional manual chest compressions in out-of-hospital CA patients There was good neurologic outcome in the vast majority of the survivors in both groups Thus, in clinical practise CPR with the LUCAS device and defebrillation during ongoing compressions seems to have similar effectiveness as manual chest compressions